alexa Characteristics of Drug-Susceptible and Drug-Resistant Staphylococcus aureus Pneumonia in Patients with HIV | OMICS International | Abstract
ISSN: 2161-1165

Epidemiology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Characteristics of Drug-Susceptible and Drug-Resistant Staphylococcus aureus Pneumonia in Patients with HIV

Charles K. Everett1*, Anuradha Subramanian3, Leah G. Jarlsberg1, Matthew Fei4 and Laurence Huang1,2

1Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, Box 0841, San Francisco, CA, USA

2Division of HIV/AIDS, University of California, San Francisco, San Francisco General Hospital, Ward 84, 995 Potrero Avenue, San Francisco, CA 94110, USA

3Division of Infectious Diseases, Department of Medicine, University of Maryland, 655 West Baltimore Street, Baltimore, MD 21201, USA

4Division of Pulmonary and Critical Care Medicine, Department of Medicine, Group Health Bellevue Medical Center, 11511 NE 10th St # 3, Bellevue, WA, USA

*Corresponding Author:
Charles K. Everett
Pulmonary and Critical Care Medicine
Box 0841, San Francisco General Hospital
1001 Potrero Avenue, San Francisco, CA 94110, USA
Tel: (415) 206-2487
Fax: (415) 695-1551
E-mail: [email protected]

Received date: April 05, 2013; Accepted date: May 02, 2013; Published date: May 06, 2013

Citation: Everett CK, Subramanian A, Jarlsberg LG, Fei M, Huang L (2013) Characteristics of Drug-Susceptible and Drug-Resistant Staphylococcus aureus Pneumonia in Patients with HIV. Epidemiol 3:122. doi: 10.4172/2161-1165.1000122

Copyright: © 2013 Everett CK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Objectives: To examine predictors and outcomes of Staphylococcus aureus Pneumonia (SAP) in people with HIV compared with Streptococcus pneumoniae Pneumonia (SPP), and to compare Methicillin-Resistant S. aureus (MRSA) with Methicillin-Sensitive S. aureus (MSSA) pneumonias in this population.

Methods: We conducted a retrospective case-control study of HIV-infected patients admitted to a single center with culture-proven S. aureus or S. pneumoniae pneumonia. We identified patients through a computerized database, conducted structured chart reviews, and performed bivariate and multivariate analyses using logistic regression.

Results: We compared 47 SAP episodes in 42 patients with 100 SPP episodes in 93 patients. Use of any antibiotics prior to admission (OR=3.5, p=0.02), a co-morbid illness (OR=4.2, p=0.04), and recent healthcare contact (OR=12.0, p<0.001) were significant independent predictors of SAP. Patients with SAP were more likely to require intensive care (OR=2.7, p=0.02) and mechanical ventilation (OR=3.1, p=0.02), but not to die. MRSA was more common (57% of cases) than MSSA, but outcomes were not significantly worse.

Conclusions: Patients with HIV and SAP have worse outcomes than those with SPP. Clinicians should consider empiric antibiotic coverage for MRSA in patients admitted with HIV and pneumonia, given the high prevalence of MRSA. Further studies are warranted to examine morbidity differences between HIV-associated MSSA and MRSA pneumonia.

Keywords

Recommended Conferences

Annual meet on Epidemiology and Public Health

Yokohama, Japan
Share This Page
 
Top